Advertisement
Advertisement
U.S. markets close in 3 hours 52 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Prometheus Biosciences, Inc. (RXDX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
109.28-4.39 (-3.86%)
As of 12:05PM EST. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Williams %R

Williams %R

Previous Close113.66
Open113.08
Bid108.85 x 900
Ask109.32 x 800
Day's Range108.45 - 114.50
52 Week Range21.50 - 122.75
Volume125,385
Avg. Volume907,320
Market Cap5.08B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-2.78
Earnings DateMay 13, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est148.64
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for RXDX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Prometheus Biosciences, Inc.
    Analyst Report: Pfizer Inc.Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.
    Rating
    Fair Value
    Economic Moat
    23 hours agoMorningstar
View more
Advertisement
Advertisement